SCHEMBL13488797

SCHEMBL13488797

CCc1ccc(Sc2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.42
ACHE P22303 4/20 0.42
ALDH1A1 P00352 1/20 0.42
EPHX2 P34913 2/20 0.41
NR1H4 Q96RI1 2/20 0.41
PTGIR P43119 1/20 0.40
TSHR P16473 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KCNH2 Q12809 1/20 0.39
TP53 P04637 1/20 0.39
KIF11 P52732 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.38
TYR P14679 1/20 0.38
GRIA4 P48058 1/20 0.38
DAO P14920 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22653014 0.94 BCHE (0.39) BCHEACHEALDH1A1EPHX2NR1H4
SCHEMBL338386 0.87 BCHE (0.52) BCHEACHETSHRKCNH2TP53
SCHEMBL576175 0.84 TP53 (0.48) ALDH1A1TSHRL3MBTL1TP53SMN1; SMN2
SCHEMBL2271509 0.84 TSHR (0.52) ALDH1A1PTGIRTSHRNPC1RAB9A
SCHEMBL18159470 0.84 TP53 (0.48) ALDH1A1TSHRL3MBTL1TP53SMN1; SMN2
SCHEMBL13488787 0.84 MCL1 (0.47) NPC1RAB9AKCNH2TP53KIF11
SCHEMBL18643754 0.80 KIF11 (0.52) BCHEACHETSHRNPC1RAB9A
SCHEMBL13985235 0.79 MCL1 (0.49) ALDH1A1PTGIRTSHRNPC1RAB9A
SCHEMBL16933906 0.78 EGFR (0.42) ALDH1A1NPC1RAB9ATP53SMN1; SMN2
SCHEMBL19532057 0.78 TSHR (0.46) ALDH1A1PTGIRTSHRKIF11SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100036136-A1 Maleimide Containing Ester and Sulfide Functionalities HENKEL AG & CO. KGAA (DE) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100036136-A1 Maleimide Containing Ester and Sulfide Functionalities EPCAM, ILK, TST BCHE 3032/4885ACHE 740/4885ALDH1A1 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.